[HTML][HTML] An update on psychopharmacological treatment of autism spectrum disorder

R Aishworiya, T Valica, R Hagerman, B Restrepo - Neurotherapeutics, 2022 - Elsevier
While behavioral interventions remain the mainstay of treatment of autism spectrum disorder
(ASD), several potential targeted treatments addressing the underlying neurophysiology of …

Autism spectrum disorder: classification, diagnosis and therapy

SR Sharma, X Gonda, FI Tarazi - Pharmacology & therapeutics, 2018 - Elsevier
Abstract Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorders
including autism, Asperger's syndrome (AS) and pervasive developmental disorder-not …

An overview of autism spectrum disorder, heterogeneity and treatment options

A Masi, MM DeMayo, N Glozier, AJ Guastella - Neuroscience bulletin, 2017 - Springer
Since the documented observations of Kanner in 1943, there has been great debate about
the diagnoses, the sub-types, and the diagnostic threshold that relates to what is now known …

Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research

DS Quintana, A Lischke, S Grace, D Scheele… - Molecular …, 2021 - nature.com
Reports on the modulatory role of the neuropeptide oxytocin on social cognition and
behavior have steadily increased over the last two decades, stimulating considerable …

Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration

TG Dinan, JF Cryan - The Journal of physiology, 2017 - Wiley Online Library
There is a growing realisation that the gut–brain axis and its regulation by the microbiota
may play a key role in the biological and physiological basis of neurodevelopmental, age …

The role of GABAergic signalling in neurodevelopmental disorders

X Tang, R Jaenisch, M Sur - Nature Reviews Neuroscience, 2021 - nature.com
GABAergic inhibition shapes the connectivity, activity and plasticity of the brain. A series of
exciting new discoveries provides compelling evidence that disruptions in a number of key …

Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology

OD Howes, M Rogdaki, JL Findon… - Journal of …, 2018 - journals.sagepub.com
An expert review of the aetiology, assessment, and treatment of autism spectrum disorder,
and recommendations for diagnosis, management and service provision was coordinated …

Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism

KJ Parker, O Oztan, RA Libove… - Proceedings of the …, 2017 - National Acad Sciences
Autism spectrum disorder (ASD) is characterized by core social deficits. Prognosis is poor, in
part, because existing medications target only associated ASD features. Emerging evidence …

An allostatic theory of oxytocin

DS Quintana, AJ Guastella - Trends in cognitive sciences, 2020 - cell.com
Oxytocin has garnered considerable interest for its role in social behavior, as well as for the
potential of intranasal administration to treat social difficulties. However, current theoretical …

An update on pharmacotherapy of autism spectrum disorder in children and adolescents

R Goel, JS Hong, RL Findling, NY Ji - International review of …, 2018 - Taylor & Francis
To date, no medication is proven to be effective in treating core symptoms of autism
spectrum disorder (ASD). Psychotropic medications are widely used to target emotional and …